Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MBVP Chemotherapy and Radiotherapy in PCNSL
NCT00003061Phase 2Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Jul 1997
- Primary completion
- Mar 2002
- Modality
- Orthosteric Ligands
- Countries
- 3
01
Overview
Phase 2, open-label, single-arm trial of methotrexate and cytarabine in primary central nervous system lymphoma (PCNSL), sponsored by European Organisation for Research and Treatment of Cancer. Primary endpoints: Response Rate and Safety and Adverse Events. Started Jul 1997; status: completed.
02
Drugs
methotrexatecytarabine
03
Conditions
primary central nervous system lymphoma (PCNSL)
Beyond the preview
Go deeper on NCT00003061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003061.